| Sanctorum, Hermes (Paleo 202302 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Paleo B.V. |
Belgium |
| Sand, Roland (Glycotope 201601 Board Chairman) |
Board member, non-executive |
Glycotope (Group) |
Germany |
| Sandal, Thomas (Crescendo Biologics 201701 VP RnD) |
Research & Development Manager |
Crescendo Biologics Ltd. |
United Kingdom (GB) |
| Sandbrink, Rupert (Topas Therapeutics 201710– CDO + CMO before Forward Pharma A/S + Bayer AG + Schering AG) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Topas Therapeutics GmbH |
Germany |
| Sander, Stephan (Fassisi 201102 Managing Director) |
Managing Director |
Fassisi, Gesellschaft für Veterinärdiagnostik und Umweltanalysen mbH |
Germany |
| Sanders, Alan (Bruker 201411 Director of Marketing at Bruker Detection) |
Sales Manager / Marketing Manager |
Bruker (Group) |
United States (USA) |
| Sanders, Alan (Bruker 201511 Director of Marketing at Bruker Detection) |
Sales Manager / Marketing Manager |
Bruker (Group) |
Germany |
| Sanders, Heiner (Alpha Metrix Biotech 200512) |
n. a. |
Alpha Metrix Biotech GmbH |
Germany |
| Sanders, Ian (Toximet 201406– CEO before EVP Sales + Applications at Bruker Life Science) |
Chief Executive Officer (CEO) |
Bio-Check (UK) (Group) |
United Kingdom (GB) |
| Sanders, Mark (Thermo Fisher 201506 Director Software Development Platform) |
Product Manager (personnel) |
Thermo Fisher (Group) |
United States (USA) |
| Sandig, Volker (ProBioGen 201004 promoted CSO since 2000 at ProBiogGen before Merck US) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Minapharm (Group) |
Germany |
| Sandin, Mary Beth (Affimed 202101 Head of Marketing + Communications) |
Public Relations Manager / Investor Relations Manager |
Affimed (Group) |
Germany |
| Sando, Gregg (Cell Medica 2006–201807 CEO + Founder RESIGNED 8/18) |
Chief Executive Officer (CEO) |
Athenex (Group) |
United Kingdom (GB) |
| Sandor, Victor (ADC Therapeutics 202004– Board Director before CMO at Array BioPharma + Incyte + Biogen Idec + AZ) |
Board member, non-executive |
ADC Therapeutics (Group) |
Switzerland |
| Sanghera, Jas (TTP Labtech 201606– Chairman before Managing Director + Commercial Director + Co-founder) |
Board member, non-executive |
SPT Labtech (Group) |
United Kingdom (GB) |
| Sansawat, Supreeya (SGS 201012 Global Manager of Food Services) |
n. a. |
SGS (Group) |
Switzerland |
| Santagostino, Alberto (Lonza 201906 SVP Head of Cell + Gene Technologies at Lonza Pharma + Biotech) |
President/Director/Head Business Group/Unit/Division |
Lonza (Group) |
Switzerland |
| Santarelli, Luca (VectivBio 202001– CEO before Therachon CEO + Roche 201110 Global Head Neuroscience Translational Area) |
Research & Development Manager |
VectivBio (Group) |
Switzerland |
| Santel, Donald J. (Hyperion Therapeutics 200806– CEO before CoTherix CEO) |
Chief Executive Officer (CEO) |
Horizon Therapeutics (Group) |
United States (USA) |
| Santi, Davide (Italy (govt) 202210 Senior investment Manager at CDP VC Technology Transfer Fund + Board Member EXTEND) |
Investment Manager |
Italy (govt) |
Italy |
| Santner, Friedrich (Anton Paar 201311 CEO) |
Chief Executive Officer (CEO) |
Anton Paar (Group) |
Austria |
| Santner, Roswitha (Applera Seutschland 200809) |
n. a. |
Thermo Fisher (Group) |
Germany |
| Santoro, Massimo (Schauenburg 201412– Technical Marketing Director at Markes before Thermo Fisher + PerkinElmer) |
Sales Manager / Marketing Manager |
Schauenburg (Group) |
United Kingdom (GB) |
| Santos da Silva, Jorge P. (MoonLake 202107– CEO before nearly 15 years at McKinsey) |
Consultant (economic/technology) |
MoonLake Immunotherapeutics AG |
Switzerland |
| Santos, Helena (Scientific Industries 202010 CEO) |
Chief Executive Officer (CEO) |
Scientific Industries (Group) |
United States (USA) |
| Sanyal, Sunny (Varian Medical Systems 201412 President Varian Imaging Components) |
President/Director/Head Business Group/Unit/Division |
Varian Medical Systems (Group) |
United States (USA) |
| Sapountzis, Ioannis (Boehringer 202007 Global Head Business Development + Licensing) |
Business Development Manager / Strategy Manager |
Boehringer Ingelheim (Group) |
Germany |
| Sardina, Marco (Panakès Partners 202107–) |
n. a. |
Panakès Partners (Group) |
Italy |
| Sargent, William (Will) (Nabriva 201510– VP Commercial Strategy + IR before Auxilium + BofA + Amgen + Immunex) |
Corporate Strategy Manager |
Nabriva (Group) |
United States (USA) |
| Sarif, Zina (Yendou 202205– Managing Director + Founder) |
Managing Director |
Yendou UG (haftungsbeschränkt) |
Germany |
| Sarronwala, Sudhanshu (Suds) (Infarm 202012 Chief Impact Officer) |
n. a. |
Infarm – Indoor Urban Farming GmbH |
Germany |
| Sarto, Christian (Bayer 201307– Managing Director of Steigerwald GmbH before Bayer HealthCare M&A) |
Managing Director |
Bayer (Group) |
Germany |
| Sarx, Johannes (Austria (govt) 201310 Managing Direcor of LISAvienna) |
Managing Director |
Austria (govt) |
Austria |
| Sasov, Alexander (Bruker 201204– Managing Director of Bruker microCT before SkyScan NV CEO + founder) |
Managing Director |
Bruker (Group) |
Belgium |
| Sasse, Frank (Axel Semrau 202111 Managing Director) |
Managing Director |
Trajan (Group) |
Germany |
| Sasshofer, Siegfried (Tecan 200702 Head Marketing Detection Business) |
Sales Manager / Marketing Manager |
Tecan (Group) |
|
| Sato, Vicki (Harvard Univ 2001104 Prof + Atlas Venture Business Adivisor before Vertex President + CSO before Biogen) |
Board member, non-executive |
Harvard University |
United States (USA) |
| Sauer, Dirk (Novartis 202012 Head of Ophthalmology Franchise at Novartis Pharma AG( |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Switzerland |
| Sauer, Uwe (ETH Zurich 201007 Institute of Molecular Systems Biology) |
Researcher (university / research institute) |
ETH Zürich (ETHZ) |
Switzerland |
| Sauer-Odendahl, Bastian (Evotec 201307– Global Head of Human Resources) |
Human Resources Manager |
Evotec (Group) |
Germany |
| Sauermann, Stefan (AnagnosTec 200912 CEO + CFO joined 2/02 as CFO) |
Managing Director |
AnagnosTec Gesellschaft für Analytische Biochemie und Diagnostik mbH |
Germany |
| Saunders, Andrew (Redx Pharma 201801– CMO before Lytix Biopharma + Linden Oncology Ltd + Eli Lilly + Roche) |
Chief Medical Officer (CMO) |
Lytix Biopharma AS |
Norway |
| Saunders, Lee (Dentons 201412 PR + Communications Manager UKMEA) |
Public Relations Manager / Investor Relations Manager |
Dentons (Group) |
United Kingdom (GB) |
| Sause, Matt (Roche 202303 CEO of Roche Diagnostics) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
| Sauter, Eberhard (Helmholtz 200908 Alfred Wegener Institute) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Savage, Karen (Rentschler 201911 VP + Head of Milford Site) |
President/Director/Head Business Group/Unit/Division |
Rentschler (Group) |
United States (USA) |
| Savelkoul, Paul (Microbiome 201503 CEO) |
Chief Executive Officer (CEO) |
Microbiome (NL) |
Netherlands |
| Savitsky, Alexander (AN Bach Institute 201109) |
Professor |
Russian Academy of Sciences (RAS/EIMB) |
Russian Federation |
| Savitsky, Kinneret (FuturX 202012 CEO before BioLineRx 201001–201610 CEO joined 2004 before BioLine Innovations + CGEN) |
Chief Executive Officer (CEO) |
FutuRx Ltd. Biotechnology Incubator |
Israel |
| Savitzky, Rodolfo (Lonza 201801 CFO) |
Chief Financial Officer (CFO) |
Lonza (Group) |
Switzerland |
| Saxton, Tracy (Nan Fung 2201703– Managing Partner + Founder of Pivotal BioVenture Partners) |
Managing Partner (investment firm) |
Nan Fung (Group) |
United States (USA) |
| Saynor, Richard (Novartis 2019Q1– CEO of Sandoz) |
Chief Executive Officer (CEO) |
Novartis (Group) |
Germany |
| Saßmannshausen, Dirk (ECBF 202202) |
n. a. |
ECBF (European Circular Bioeconomy Fund) (Group) |
Germany |
| Scangos, George A. (Biogen Idec 201007– CEO before Exelixis 199611– CEO before Bayer) |
Chief Executive Officer (CEO) |
Biogen (Group) |
United States (USA) |
| Scarrott, Alison (Chaz Brooks Communciations 201209 Account Manager) |
Public Relations Manager / Investor Relations Manager |
Chaz Brooks Communications Ltd. (CBC) |
United Kingdom (GB) |
| Scemama, Isabelle (Axa 202107 Global Head of AXA IM Alts & CEO of AXA IM Real Assets) |
President/Director/Head Business Group/Unit/Division |
Axa (Group) |
France |
| Schaab, Christoph (Evotec 202109 SVP Head of Proteomics + Metabolomics) |
President/Director/Head Business Group/Unit/Division |
Evotec (Group) |
Germany |
| Schaaf, Andreas (Greenovation Biotech 201911– Managing Director) |
Managing Director |
Eleva GmbH |
Germany |
| Schaback, Johannes (ladenzeile.de Founder + Home24 Founder) |
n. a. |
|
|
| Schacherer, Frank (Biobase 201105 Managing Director (COO) joined Biobase 2005 as Director Biobase Corp) |
Managing Director |
Qiagen (Group) |
Germany |
| Schacht, Oliver (Curetis 201012– CEO before Epigenomics CFO) |
Chief Executive Officer (CEO) |
OpGen (Group) |
Germany |
| Schad, Martina (OakLabs GmbH 201103–Managing Director + founder before imaGenes Assoc Director Microarray Services) |
Managing Director |
OakLabs GmbH |
Germany |
| Schaefer, Burkhard (BSSN Software GmbH 201908 Managing Director) |
Managing Director |
Merck (DE) (Group) |
Germany |
| Schaeske, Frank (Mettler-Toledo GmbH 201711 Senior Marcom Manager LAB + Product Manager Analytical Instruments) |
Sales Manager / Marketing Manager |
Mettler-Toledo (Mettler Toledo) (Group) |
Germany |
| Schafberger, Bernd (Bayer (govt) 201409 Investment Manager at Bayern Kapital) |
Investment Manager |
Bavaria (govt region) |
Germany |
| Schaffarczyk, Dietmar Stefan (stimOS GmbH 201707 Managing Director) |
Managing Director |
|
|
| Schaffer, Thomas (Biofrontera 201306– CFO before Siemens et al) |
Chief Financial Officer (CFO) |
Biofrontera (Group) |
Germany |
| Schaffert, Susanne (Novartis 201901–2022 CEO of Oncology Business Unit joined Novartis >20 years ago RETIRED 2022) |
Chief Executive Officer (CEO) |
Novartis (Group) |
Switzerland |
| Schaft, Julia (BioRN 202205 Managing Director) |
Managing Director |
BioRN Network e. V. |
Germany |
| Schaier, Matthias (TolerogenixX GmbH 201612– Managing Director) |
Managing Director |
TolerogenixX GmbH |
Germany |
| Schalken, Jack (Univ Nijmegen 2013 Professor + Founder of Oncodrone BV) |
Professor |
University of Nijmegen (Radboud University) |
Netherlands |
| Schalper, Claus (Isarna Therapeutics 202109– CEO before XL-protein+ Pieris) |
Managing Director |
Isarna Therapeutics GmbH |
Germany |
| Schambye, Hans T. (Galecto Biotech 201111– CEO before OncoNOx + Reception + Gastrotech + Maxygen + ProFound Pharma) |
Chief Executive Officer (CEO) |
Galecto (Group) |
Denmark |
| Schanche, Jon-Sverre (Thermo Fisher 201605 VP RnD for ImmunoDiagnostics business) |
Research & Development Manager |
Thermo Fisher (Group) |
United States (USA) |
| Schapeler, Dirk (Bayer 201711 Head of LifeScience iHUB) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
United States (USA) |
| Scharrer, Nicola (ITM Isotopen Technologien München 201603 Head of Marketing) |
Sales Manager / Marketing Manager |
ITM (Group) |
Germany |
| Schatz, Peer M. (Resolve BioSciences 202012 Chairman + Co-Founder before Qiagen 1993–201910 CEO RESIGNED 10/19) |
Board member, non-executive |
PS Capital Management GmbH (Peer Schatz) |
Germany |
| Schatzschneider, Michael (Creapaper 202110 CFO before Euronext 2017– Director + BHF Bank + Commerzbank) |
Chief Financial Officer (CFO) |
Creapaper GmbH |
Germany |
| Schaub, Christian (Redbiotec 201501 CEO) |
Chief Executive Officer (CEO) |
Redbiotec AG |
Switzerland |
| Schaude, Michael (Quantapore 201406 Board Member before Bender MedSystems 1998–2009 CEO + Boehringer) |
Chief Executive Officer (CEO) |
Thermo Fisher (Group) |
Austria |
| Schauenburg, Florian G. (Schauenburg 201301 CEO) |
Chief Executive Officer (CEO) |
Schauenburg (Group) |
Germany |
| Schauer, Nicolas (Biocrates 201909– Co-CEO + CSO before Metabolomic Discoveries Managing Director + Founder) |
Managing Director |
Metabolon (Group) |
Germany |
| Schavan, Annette (BMBF 2006) |
n. a. |
Germany (govt) |
Germany |
| Schecher, Sabrina (Immatics 202309 Senior Director Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Immatics (Group) |
Netherlands |
| Scheefers, Hans (ScheBo Biotech 201102 Executive Director) |
Board member, executive |
ScheBo Biotech (Group) |
Germany |
| Scheefers-Borchel, Ursula (ScheBo Biotech 201102 Executive Director) |
Board member, executive |
ScheBo Biotech (Group) |
Germany |
| Scheefhals, Guus (Crossbeta Biosciences 201303 CEO) |
Chief Executive Officer (CEO) |
Crossbeta Biosciences B.V. |
Netherlands |
| Scheek, Sigrid (Ascenion 200801 Technology Manager) |
IP Manager |
Life Science-Stiftung (LifeScience Foundation) (Group) |
Germany |
| Scheel, Andreas (Evotec 202004 EVP Head of Cell Therapy + PanCella 202004– Supervisory Board Member) |
President/Director/Head Business Group/Unit/Division |
Evotec (Group) |
Germany |
| Scheer, Alexander (Erytech 201610– CSO before Pierre Fabre + Merck Serono + Serono) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Erytech (Group) |
France |
| Scheer, Nico (Cevec 201511– VP Business Development Glycoproteins before Taconic Biosciences/Artemis) |
Business Development Manager / Strategy Manager |
Danaher (Group) |
Germany |
| Scheffer, Petra (Bruker Corp 201701 Director of MarCom at Bruker Daltonics) |
Sales Manager / Marketing Manager |
Bruker (Group) |
Germany |
| Scheffler, Matthias (Biocrates 201911 CBO + Head Marketing + Sales before Febit) |
Chief Business Officer (CBO) |
Biocrates (Group) |
Austria |
| Schefold, Christian (Dentons 201501– Counsel before Counsel at Daimler + Daimler Financial Services) |
Attorney / Lawyer |
Dentons (Group) |
Switzerland |
| Scheibner, Holger (IMI Consulting 200503) |
n. a. |
IMI Consulting GmbH |
Germany |
| Scheidegger, Alfred (Nextech Invest 201104 CEO + Founding Partner) |
Chief Executive Officer (CEO) |
Nextech (Group) |
Switzerland |
| Scheidle, Jörg (Immatics 200501– CFO before BrainLab) |
Chief Financial Officer (CFO) |
Immatics (Group) |
Germany |
| Scheiflinger, Friedrich (Fritz) (Evotec 202004 EVP Head Gene Therapy before Shire/Takeda 201707 Head Global Research) |
President/Director/Head Business Group/Unit/Division |
Evotec Gene Therapy (Orth, AT, Evotec GT) |
Austria |
| Scheinert, Peter (AmpTec GmbH 201201 Managing Director) |
Managing Director |
Merck (DE) (Group) |
Germany |
| Scheipers, Andreas (sense2care 201101 Managing Director) |
Managing Director |
sense2care GmbH |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 65 66 67 ... 86 87 88 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
